The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

Rapidly mutating DNA regions were mapped using a multi-generational family and advanced sequencing tools. Understanding how ...

Pharmaceutical giant Regeneron has promised to prioritise the “ethical use” of the sequenced DNA data of more than 15 million ...

KMAP projects DNA sequences—known as k-mers—into two-dimensional space, making it easier to identify and interpret biologically significant DNA sequence patterns, also called DNA motifs (fig. 1).

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical ...